Status
Conditions
Treatments
About
A Randomized, Parallel-controlled, Clinical Study to Evaluate the Efficacy of Xuebi Prescription Compared With Placebo in the Treatment of Diabetic Peripheral Neuropathy(Qi Deficiency and Blood Stasis)
Full description
Charged by the sponsor in line with traditional Chinese medicine Qi deficiency and blood stasis syndrome 60 cases have DPN,they were randomly divided into Chinese herbal compound Xuebi prescription group and placebo group. The treatment groups were compared 24-week composite score.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
qiang zhou, PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal